Atlas Trials

Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia

Clinical trial NCT04429763 · UNKNOWN

Trial details

NCT number
NCT04429763
Sponsor
Trustem
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2020-07-01
Primary completion
2020-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.